Skip to main content

Table 3 Number of patients presenting with either anti- Factor IIa (thrombin) inhibitor, anti-Factor V (FV) inhibitor, or both

From: Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety

 

Bleeding Cases

N = 32

Non-Bleeding Cases

N = 32

Total

N = 64

Inhibitor Type

n (%)

n (%)

n (%)

FIIa

4 (13)

4 (12)

8 (12)

FV

17 (53)

15 (47)

32 (50)

FIIa and FV

11 (34)

13 (41)

24 (38)

  1. Sorted by clinical presentation and contained reports of a surgical setting where known or presumed bovine thrombin exposure occurred [3–35].
Back to article page

Patient Safety in Surgery

ISSN: 1754-9493